MX9701582A - Implante inyectable de gel de oxido de polietilenoy metodo para su produccion. - Google Patents

Implante inyectable de gel de oxido de polietilenoy metodo para su produccion.

Info

Publication number
MX9701582A
MX9701582A MX9701582A MX9701582A MX9701582A MX 9701582 A MX9701582 A MX 9701582A MX 9701582 A MX9701582 A MX 9701582A MX 9701582 A MX9701582 A MX 9701582A MX 9701582 A MX9701582 A MX 9701582A
Authority
MX
Mexico
Prior art keywords
polyethylene oxide
production
implant
oxide gel
gel implant
Prior art date
Application number
MX9701582A
Other languages
English (en)
Inventor
Franck L Villain
Jean-Marie A Parel
William G Lee
Gabriel Simon
Original Assignee
Univ Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Miami filed Critical Univ Miami
Publication of MX9701582A publication Critical patent/MX9701582A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0059—Cosmetic or alloplastic implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/013—Instruments for compensation of ocular refraction ; Instruments for use in cornea removal, for reshaping or performing incisions in the cornea
    • A61F9/0133—Knives or scalpels specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30—Post-polymerisation treatment, e.g. recovery, purification, drying
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/28—Treatment by wave energy or particle radiation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B2017/320044—Blunt dissectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses and implants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2371/00—Characterised by the use of polyethers obtained by reactions forming an ether link in the main chain; Derivatives of such polymers
    • C08J2371/02—Polyalkylene oxides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902—Method of implanting
    • Y10S623/905—Eye
    • Y10S623/906—Corneal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Colloid Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

Un implante biocompatible de gel de oxido de polietileno y un método para su produccion; el gel que puede inyectarse en el cuerpo humano para el reemplazo y aumento de tejidos. El implante se prepara disolviendo una muestra de oxido de polietileno esencialmente puro en una solucion salina dentro de un recipiente sellado. Retirar todo oxígeno libre del recipiente y reemplazarlo con un gas inerte como argon, e irradiar el recipiente con una fuente de rayos gama para reticular el oxido de polietileno simultáneamente mientras se esteriliza. El gel puede colocarse entonces dentro de una jeringa e inyectarse al interior del cuerpo.
MX9701582A 1994-09-01 1995-08-30 Implante inyectable de gel de oxido de polietilenoy metodo para su produccion. MX9701582A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/299,583 US5634943A (en) 1990-07-12 1994-09-01 Injectable polyethylene oxide gel implant and method for production
PCT/US1995/010733 WO1996006883A1 (en) 1994-09-01 1995-08-30 Injectable polyethylene oxide gel implant and method for production

Publications (1)

Publication Number Publication Date
MX9701582A true MX9701582A (es) 1998-03-31

Family

ID=23155423

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9701582A MX9701582A (es) 1994-09-01 1995-08-30 Implante inyectable de gel de oxido de polietilenoy metodo para su produccion.

Country Status (15)

Country Link
US (3) US5634943A (es)
EP (1) EP0778858B1 (es)
JP (1) JP3681393B2 (es)
KR (1) KR100369961B1 (es)
AT (1) ATE188499T1 (es)
AU (1) AU690327B2 (es)
BR (1) BR9508696A (es)
CA (1) CA2198906A1 (es)
CO (1) CO4440603A1 (es)
DE (1) DE69514371T2 (es)
ES (1) ES2145293T3 (es)
MX (1) MX9701582A (es)
TW (1) TW421600B (es)
WO (1) WO1996006883A1 (es)
ZA (1) ZA957331B (es)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7320962B2 (en) 1996-08-27 2008-01-22 Baxter International Inc. Hemoactive compositions and methods for their manufacture and use
US6063061A (en) * 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US6706690B2 (en) 1999-06-10 2004-03-16 Baxter Healthcare Corporation Hemoactive compositions and methods for their manufacture and use
US8003705B2 (en) 1996-09-23 2011-08-23 Incept Llc Biocompatible hydrogels made with small molecule precursors
US6566406B1 (en) 1998-12-04 2003-05-20 Incept, Llc Biocompatible crosslinked polymers
US6152943A (en) * 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
FR2786400B1 (fr) * 1998-11-30 2002-05-10 Imedex Biomateriaux Procede de preparation d'un materiau collagenique a vitesse de biodegradation in vivo controlee et materiaux obtenus
US6361560B1 (en) * 1998-12-23 2002-03-26 Anamed, Inc. Corneal implant and method of manufacture
US7635388B1 (en) * 2000-05-04 2009-12-22 Tyler Thomas D Device and method for incremental correction of sight disorders and occular diseases
EP1326506B1 (en) 2000-09-12 2016-04-27 Revision Optics, Inc. System for packaging and handling an implant
US8668735B2 (en) 2000-09-12 2014-03-11 Revision Optics, Inc. Corneal implant storage and delivery devices
US6296607B1 (en) * 2000-10-20 2001-10-02 Praxis, Llc. In situ bulking device
DE10106546A1 (de) * 2001-02-13 2002-08-22 Ethicon Gmbh Verfahren zum Herstellen eines medizinischen Implantats
US6537569B2 (en) * 2001-02-14 2003-03-25 Microvention, Inc. Radiation cross-linked hydrogels
US6482870B1 (en) * 2001-07-19 2002-11-19 Shahriar Hojjati Emami Crosslink polyethylene oxide in the melt by means of 2,5-bis(tert-butylperoxy)-2,5-dimethylhexane
KR100798058B1 (ko) * 2001-12-01 2008-01-28 가부시키가이샤 아이 메딕 뼈 고정용 임플란트
US7579442B2 (en) * 2002-04-16 2009-08-25 Ocugenics, LLC Method for stromal corneal repair and refractive alteration
US20030232287A1 (en) * 2002-06-14 2003-12-18 Bango Joseph J. Method for stromal corneal repair and refractive alteration using photolithography
US20110098790A1 (en) * 2009-10-26 2011-04-28 Albert Daxer Methods for treating corneal disease
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
GB2406854A (en) * 2003-09-03 2005-04-13 Frederick Pearson Method and apparatus for sterilising a material or treating carbonaceous material
WO2005057272A2 (en) * 2003-12-05 2005-06-23 Innfocus, Llc Improved ocular lens
JP5090742B2 (ja) * 2003-12-05 2012-12-05 インフォーカス リミテッド ライアビリティー カンパニー 改良緑内障移植デバイス
US20050186240A1 (en) * 2004-02-23 2005-08-25 Ringeisen Timothy A. Gel suitable for implantation and delivery system
US20050220882A1 (en) * 2004-03-04 2005-10-06 Wilson Pritchard Materials for medical implants and occlusive devices
US20050234336A1 (en) * 2004-03-26 2005-10-20 Beckman Andrew T Apparatus and method for marking tissue
US10835371B2 (en) 2004-04-30 2020-11-17 Rvo 2.0, Inc. Small diameter corneal inlay methods
US7776086B2 (en) 2004-04-30 2010-08-17 Revision Optics, Inc. Aspherical corneal implant
US8057541B2 (en) 2006-02-24 2011-11-15 Revision Optics, Inc. Method of using small diameter intracorneal inlays to treat visual impairment
DE602005005506T2 (de) * 2004-08-25 2009-04-23 Union Carbide Chemicals & Plastics Technology Corp., Danbury Polymerfolie
US7919112B2 (en) * 2004-08-26 2011-04-05 Pathak Holdings, Llc Implantable tissue compositions and method
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
WO2006102676A1 (en) * 2005-03-23 2006-09-28 Tissue Engineering Refraction, Inc. Injectable polyethylene oxide dermal fillers and related devices
EP1933751A4 (en) * 2005-10-13 2009-12-02 Shui T Lai INTRASTROMAL REFRACTIVE SURGERY BY INDUCTION OF SHAPE CHANGES IN THE HORN SKIN
US10555805B2 (en) 2006-02-24 2020-02-11 Rvo 2.0, Inc. Anterior corneal shapes and methods of providing the shapes
ES2523690T3 (es) 2006-05-23 2014-11-28 Daxer, Albert Implante corneal para la corrección de defectos de visión del ojo humano
WO2007140312A2 (en) * 2006-05-25 2007-12-06 The General Hospital Corporation Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US9549848B2 (en) 2007-03-28 2017-01-24 Revision Optics, Inc. Corneal implant inserters and methods of use
US9271828B2 (en) 2007-03-28 2016-03-01 Revision Optics, Inc. Corneal implant retaining devices and methods of use
US8162953B2 (en) 2007-03-28 2012-04-24 Revision Optics, Inc. Insertion system for corneal implants
CN201075472Y (zh) * 2007-05-28 2008-06-18 富士康(昆山)电脑接插件有限公司 电连接器
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
US20090220578A1 (en) * 2008-02-28 2009-09-03 Depuy Products, Inc. Hydrogel composition and method for making the same
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US8745133B2 (en) * 2008-03-28 2014-06-03 Yahoo! Inc. System and method for optimizing the storage of data
US9539143B2 (en) 2008-04-04 2017-01-10 Revision Optics, Inc. Methods of correcting vision
WO2009124268A2 (en) 2008-04-04 2009-10-08 Revision Optics, Inc. Corneal inlay design and methods of correcting vision
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
PL2442835T3 (pl) 2009-06-16 2015-07-31 Baxter Int Gąbka hemostatyczna
CA2769340C (en) 2009-07-31 2018-09-11 Harald Rau Prodrugs comprising an insulin linker conjugate
MA33466B1 (fr) 2009-07-31 2012-07-03 Sanofi Aventis Deutschland Composition d'insuline à longue duree d'action
WO2011051406A1 (en) 2009-10-29 2011-05-05 Ascendis Pharma As Sterilization of biodegradable hydrogels
BR112012014773A2 (pt) 2009-12-16 2015-11-03 Baxter Healthcare Sa esponja de compósito hemostática, método para fabricar uma esponja de compósito hemostática, e, uso da referida esponja
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
JP5973997B2 (ja) 2010-06-01 2016-08-23 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血用組成物を作製するためのプロセス
BR112012030457B1 (pt) 2010-06-01 2021-03-09 Baxter International Inc. processo para fabricar uma composição hemostática seca e estável, recipiente acabado final, método para prover uma composição hemostática pronta para uso, e, kit para administrar uma composição hemostática
US8469948B2 (en) 2010-08-23 2013-06-25 Revision Optics, Inc. Methods and devices for forming corneal channels
EP2438930A1 (en) 2010-09-17 2012-04-11 Sanofi-Aventis Deutschland GmbH Prodrugs comprising an exendin linker conjugate
KR101272484B1 (ko) * 2011-01-19 2013-06-10 세원셀론텍(주) 방사선 가교화된 콜라겐 겔 및 그 제조방법과 사용방법
US20130096063A1 (en) 2011-10-11 2013-04-18 Baxter Healthcare S.A. Hemostatic compositions
EP2766058B1 (en) 2011-10-11 2022-11-23 Baxter International Inc. Hemostatic compositions
KR101762932B1 (ko) 2011-10-21 2017-08-04 리비젼 옵틱스, 인크. 각막 이식물 저장 및 전달 디바이스
RU2014121232A (ru) 2011-10-27 2015-12-10 Бакстер Интернэшнл Инк. Гемостатические композиции
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
RU2700162C2 (ru) 2013-06-21 2019-09-13 Ферросан Медикал Дивайсиз А/С Расширенная под вакуумом сухая композиция и шприц для ее сохранения
EP3079731B1 (en) 2013-12-11 2018-08-08 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
WO2016144404A1 (en) 2015-03-12 2016-09-15 Revision Optics, Inc. Methods of correcting vision
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN105169469B (zh) * 2015-08-29 2018-05-25 北京诺康达医药科技有限公司 一种组织密封剂及其制备方法和应用
CN112368028A (zh) 2018-05-09 2021-02-12 弗罗桑医疗设备公司 用于制备止血组合物的方法
US11864990B2 (en) * 2019-02-26 2024-01-09 Avedro, Inc. Bioresorbable corneal implants
CN112679726B (zh) * 2020-12-23 2023-03-17 鸡西市唯大新材料科技有限公司 用聚氧化乙烯制备具有亲油及亲水性透明有机凝胶的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB117032A (en) * 1917-12-31 1918-07-04 Albert Edgar Alexander Cleaning Shop for Cleansing Work by Means of a Sand Jet.
US3264202A (en) * 1961-06-13 1966-08-02 Union Carbide Corp Ionizing radiation of water solution of polyalkylene oxide and product thereof
FR1441586A (fr) * 1965-04-21 1966-06-10 Centre Nat Rech Scient Gel de polyoxyéthylèneglycol et procédé de préparation
US3419006A (en) * 1966-08-08 1968-12-31 Union Carbide Corp Novel dressing and use thereof
US4381320A (en) * 1981-06-03 1983-04-26 Johnson & Johnson Non-ionic absorbent polymers
DE3343674A1 (de) * 1983-12-02 1985-09-05 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von (alpha) -substituierten acrylsaeureamiden
US4790919A (en) * 1984-06-28 1988-12-13 E. I. Du Pont De Nemours And Company Process for preparation of electrophoresis gel material
US4883699A (en) * 1984-09-21 1989-11-28 Menlo Care, Inc. Polymeric article having high tensile energy to break when hydrated
US4911691A (en) * 1984-09-21 1990-03-27 Menlo Care, Inc. Assembly for adminstering IV solution
US4616644A (en) * 1985-06-14 1986-10-14 Johnson & Johnson Products, Inc. Hemostatic adhesive bandage
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
GB8615701D0 (en) * 1986-06-27 1986-08-06 Delta Biotechnology Ltd Stable gene integration vector
US4684558A (en) * 1986-06-30 1987-08-04 Nepera Inc. Adhesive polyethylene oxide hydrogel sheet and its production
US4706680A (en) * 1986-06-30 1987-11-17 Nepera Inc. Conductive adhesive medical electrode assemblies
GB8717799D0 (en) * 1987-07-28 1987-09-03 Atomic Energy Authority Uk Polymer electrolytes
US5143071A (en) * 1989-03-30 1992-09-01 Nepera, Inc. Non-stringy adhesive hydrophilic gels
AU4381793A (en) * 1992-05-20 1993-12-13 Cytrx Corporation Gel composition for implant prosthesis and method of use
WO1994017851A1 (en) * 1993-02-08 1994-08-18 Massachusetts Institute Of Technology Bilayer composite hydrogels for corneal prostheses
FR2707499B1 (fr) * 1993-04-30 1995-12-01 Patrice Navatel Procédé de formation de gels par action de rayons ionisants, et produits obtenus.

Also Published As

Publication number Publication date
US5645583A (en) 1997-07-08
AU690327B2 (en) 1998-04-23
ATE188499T1 (de) 2000-01-15
WO1996006883A1 (en) 1996-03-07
AU3413695A (en) 1996-03-22
ES2145293T3 (es) 2000-07-01
DE69514371T2 (de) 2000-08-10
KR100369961B1 (ko) 2003-03-15
DE69514371D1 (de) 2000-02-10
KR970705600A (ko) 1997-10-09
EP0778858A1 (en) 1997-06-18
JP3681393B2 (ja) 2005-08-10
US5681869A (en) 1997-10-28
CA2198906A1 (en) 1996-03-07
EP0778858B1 (en) 2000-01-05
BR9508696A (pt) 1997-09-09
JPH10505115A (ja) 1998-05-19
ZA957331B (en) 1996-04-15
TW421600B (en) 2001-02-11
CO4440603A1 (es) 1997-05-07
US5634943A (en) 1997-06-03

Similar Documents

Publication Publication Date Title
ZA957331B (en) Injectable polyethylene oxide gel implant and method for production
ES2126784T5 (es) Metodo para la preparacion de jeringuillas de plastico previamente llenas.
CA2083165C (en) Device and method for treating facial lines
US20060275336A1 (en) Preparation of an osteoinductive agent
Ramsden et al. Ionomeric bone cement in neuro-otological surgery
GR3034069T3 (en) Decontaminating blood components with 8-methoxypsoralen.
JPS51101394A (es)
US4908013A (en) Holder for a vein segment and method of removing cells from a vein segment
WO2005051457A3 (en) Delivery system and prescription method for interstitial radiation therapy using enhanced parametric release sterilization techniques
KR20160065698A (ko) 광학 플라즈마를 이용한 임플란트 표면 처리 방법 및 이를 수행하는 임플란트 표면 처리 장치
AU2002305907A1 (en) Method for sterilizing bioactive materials
WO2002070024A1 (en) Method for sterilizing bioactive materials
JP2003527197A (ja) 埋植材料用の調製および注入装置
KR102351510B1 (ko) 플라즈마 치과 임플란트 캡슐레이션 장치
DE10103706A1 (de) Verwendung eines Hydrogenperoxid-Plasma-Sterilisationsverfahrens für die schonende Sterilisation temperaturempfindlicher Produkte
Cakir et al. Experimental Evaluation of the Effects of Ankaferd Blood Stopperand Collagenated Heterologous Bone Graft on Bone Healing in Sinus Floor Augmentation.
CH643732A5 (en) Aid for covering and/or filling bone defects and process for the production thereof
US7357895B2 (en) Method for sterilizing bioactive materials
CN103203034B (zh) 一种高能电子射线消毒装置及其应用
Kotenko et al. Shape-memory dental quadriradical implants for single-stage immediate implantation and undelayed dental prosthetics
RU2297250C2 (ru) Трансплантационная смесь
JPH0653153B2 (ja) 多孔質人工骨材料の貯蔵方法及び処理方法
NZ228435A (en) Sterilised container and method of sterilisation using a saline solution which has been sterilised by an electrolytic cell
MD884G2 (ro) Procedeu de activizare a osteogenezei reparatorii
RU93048621A (ru) Способ устранения дефекта костной ткани